Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
VIPergic neurons of the infralimbic and prelimbic cortices control palatable food intake through separate cognitive pathways
Brandon A. Newmyer, Ciarra M. Whindleton, Peter M. Klein, Mark P. Beenhakker, Marieke K. Jones, Michael M. Scott
Brandon A. Newmyer, Ciarra M. Whindleton, Peter M. Klein, Mark P. Beenhakker, Marieke K. Jones, Michael M. Scott
View: Text | PDF
Research Article Metabolism Neuroscience

VIPergic neurons of the infralimbic and prelimbic cortices control palatable food intake through separate cognitive pathways

  • Text
  • PDF
Abstract

The prefrontal cortex controls food reward seeking and ingestion, playing important roles in directing attention, regulating motivation toward reward pursuit, and assigning reward salience and value. The cell types that mediate these behavioral functions, however, are not well described. We report here that optogenetic activation of vasoactive intestinal peptide–expressing (VIP-expressing) interneurons in both the infralimbic (IL) and prelimbic (PL) divisions of the medial prefrontal cortex in mice is sufficient to reduce acute, binge-like intake of high-calorie palatable food in the absence of any effect on low-calorie rodent chow intake in the sated animal. In addition, we discovered that the behavioral mechanisms associated with these changes in feeding differed between animals that underwent either IL or PL VIPergic stimulation. Although IL VIP neurons showed the ability to reduce palatable food intake, this effect was dependent upon the novelty and relative value of the food source. In addition, IL VIP neuron activation significantly reduced novel object and novel social investigative behavior. Activation of PL VIP neurons, however, produced a reduction in high-calorie palatable food intake that was independent of food novelty. Neither IL nor PL VIP excitation changed motivation to obtain food reward. Our data show how neurochemically defined populations of cortical interneurons can regulate specific aspects of food reward–driven behavior, resulting in a selective reduction in intake of highly valued food.

Authors

Brandon A. Newmyer, Ciarra M. Whindleton, Peter M. Klein, Mark P. Beenhakker, Marieke K. Jones, Michael M. Scott

×

Figure 3

SSFO stimulation of PL VIPergic neurons produces a selective increase in c-Fos expression throughout the PL.

Options: View larger image (or click on image) Download as PowerPoint
SSFO stimulation of PL VIPergic neurons produces a selective increase in...
PL SSFO stimulation results in an increase in c-Fos expression (F) when compared with controls (E) quantified in (D). PL SSFO stimulation does not result in an increase in c-Fos expression in the IL, when stimulated animals (C) are compared with controls (B) quantified in (A). Scale bar: 200 μm. Fmi, forceps minor corpus callosum. *P < 0.055, unpaired t test. 10 PL control and 7 PL SSFO mice (A and D) were used for analysis.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts